Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/40699
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDEFERM, Sebastien-
dc.contributor.authorBERTRAND, Philippe-
dc.contributor.authorDHONT, Sebastiaan-
dc.contributor.authorvon Bardeleben, Ralph S.-
dc.contributor.authorVANDERVOORT, Pieter-
dc.date.accessioned2023-08-21T10:27:05Z-
dc.date.available2023-08-21T10:27:05Z-
dc.date.issued2023-
dc.date.submitted2023-08-03T10:26:12Z-
dc.identifier.citationHeart Failure Clinics, 19 (3) , p. 357 -377-
dc.identifier.issn1551-7136-
dc.identifier.urihttp://hdl.handle.net/1942/40699-
dc.description.abstractThe aging population is rising at record pace worldwide. Along with it, a steep increase in the prevalence of atrial fibrillation and heart failure with preserved ejection fraction is to be expected. Similarly, both atrial functional mitral and tricuspid regurgitation (AFMR and AFTR) are increasingly observed in daily clinical practice. This article summarizes all current evidence regarding the epidemiology, prognosis, pathophysiology, and therapeutic options. Specific attention is addressed to discern AFMR and AFTR from their ventricular counterparts, given their different pathophysiology and therapeutic needs.-
dc.description.sponsorshipERASMUS 1-
dc.language.isoen-
dc.publisherELSEVIER SCIENCE INC-
dc.subject.otherAtrial functional mitral regurgitation-
dc.subject.otherAtrial functional tricuspid regurgitation-
dc.subject.otherAtrial fibrillation-
dc.subject.otherAtrial myopathy-
dc.subject.otherFunctional mitral regurgitation-
dc.subject.otherHeart failure with preserved ejection fraction-
dc.subject.otherIsolated tricuspid regurgitation-
dc.subject.otherLeft atrium-
dc.titleArrythmia-Mediated Valvular Heart Disease-
dc.typeJournal Contribution-
dc.identifier.epage377-
dc.identifier.issue3-
dc.identifier.spage357-
dc.identifier.volume19-
local.format.pages21-
local.bibliographicCitation.jcatA1-
dc.description.notesVandervoort, PM (corresponding author), Schiepse bos 6, B-3600 Genk, Belgium.-
dc.description.notespieter.vandervoort@zol.be-
local.publisher.placeSTE 800, 230 PARK AVE, NEW YORK, NY 10169 USA-
local.type.refereedRefereed-
local.type.specifiedArticle-
dc.identifier.doi10.1016/j.hfc.2023.02.008-
dc.identifier.pmid37230650-
dc.identifier.isi001016742700001-
dc.contributor.orcidvon Bardeleben, Ralph Stephan/0000-0002-1356-0037-
dc.identifier.eissn-
local.provider.typewosris-
local.description.affiliation[Deferm, Sebastien; von Bardeleben, Ralph S.] Hasselt Univ, Agoralaan Bldg, B-3590 Diepenbeek, Belgium.-
local.description.affiliation[Bertrand, Philippe B.; Dhont, Sebastiaan; Vandervoort, Pieter M.] Mainz Univ Hosp, Dept Cardiol, Langenbeckstr 1, Mainz, Germany.-
local.description.affiliation[Vandervoort, Pieter M.] Hosp Oost Limburg Genk, Dept Cardiol, Schiepse Bos 6, B-3600 Genk, Belgium.-
local.description.affiliation[Vandervoort, Pieter M.] Schiepse bos 6, B-3600 Genk, Belgium.-
local.uhasselt.internationalyes-
item.fulltextNo Fulltext-
item.fullcitationDEFERM, Sebastien; BERTRAND, Philippe; DHONT, Sebastiaan; von Bardeleben, Ralph S. & VANDERVOORT, Pieter (2023) Arrythmia-Mediated Valvular Heart Disease. In: Heart Failure Clinics, 19 (3) , p. 357 -377.-
item.accessRightsClosed Access-
item.contributorDEFERM, Sebastien-
item.contributorBERTRAND, Philippe-
item.contributorDHONT, Sebastiaan-
item.contributorvon Bardeleben, Ralph S.-
item.contributorVANDERVOORT, Pieter-
crisitem.journal.issn1551-7136-
Appears in Collections:Research publications
Show simple item record

WEB OF SCIENCETM
Citations

1
checked on May 8, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.